Healthy Clinical Trial
— 22HUM23661Official title:
Effects of Race Pace Based Approach on the Performance of Recreational Runners: a Randomized Controlled Trial
Verified date | January 2024 |
Source | Universidad Rey Juan Carlos |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study was to compare the performance effects of the intensity demarcation model based on the race pace based approach with the triphasic physiological model and heart rate variability guidelines (HR+HRV)
Status | Completed |
Enrollment | 28 |
Est. completion date | July 15, 2023 |
Est. primary completion date | June 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being adults - VO2max between 45 and 60 mL·min-1·kg^-1 for men - VO2max between 40 and 55 mL·min^-1 for women - More than 4 days per week of training frequency - Running experience = 2 years - Record HR data of all training sessions during the study Exclusion Criteria: - Previous injuries for at least three months - Smokers - Any cardiovascular condition that compromises health status and participation in the study |
Country | Name | City | State |
---|---|---|---|
Spain | Universidad Rey Juan Carlos | Fuenlabrada | Madrid |
Lead Sponsor | Collaborator |
---|---|
Universidad Rey Juan Carlos | GO fit Lab- Ingesport |
Spain,
Carrasco-Poyatos M, Gonzalez-Quilez A, Martinez-Gonzalez-Moro I, Granero-Gallegos A. HRV-Guided Training for Professional Endurance Athletes: A Protocol for a Cluster-Randomized Controlled Trial. Int J Environ Res Public Health. 2020 Jul 29;17(15):5465. doi: 10.3390/ijerph17155465. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline of Running Economy | Tests were performed on the treadmill and respiratory gas analysis was carried out.
The laboratory tests included: - Running economy (RE) test (ml·kg·km) RE was measured by running two blocks at constant speeds (7 and 9 km·h^-1 or 8 and 10 km·h^-1, respectively), depending on the subject's level, intensities below the first ventilatory threshold. Each block lasted three minutes. RE is one of the physiological determinants of endurance performance: an improvement in RE over time indicates an improvement in performance |
Baseline and after 6 weeks | |
Primary | Change from Baseline of VO2max | Tests were performed on the treadmill and respiratory gas analysis was carried out.
The laboratory tests included: - Maximum oxygen consumption test (VO2max) After 30 minutes of rest, a maximal incremental test was performed to calculate relative VO2max (ml·kg^-1·min^-1) and absolute VO2max (L·min^-1). The test started at the last speed of the RE test (9 or 10 km·h^-1), depending on the subject's level. The speed increased continuously by 0.5 km·h-1 every minute until exhaustion. The mean value of the last 30 s of the VO2, a respiratory exchange ratio (RER) >1.05, a HR > 95% of the maximum HR, and an RPE > 18 were the variables considered to calculate the VO2max VO2max is one of the determinants of endurance performance. The relative VO2max is influenced by weight (at equal VO2max, the runner who weighs less is more advantaged). An improvement in absolute and relative values of VO2max over time indicate an improvement in performance |
Baseline and after 6 weeks | |
Primary | Change from Baseline of Maximum aerobic velocity (VAM) | Tests were performed on the treadmill and respiratory gas analysis was carried out.
The laboratory tests included: - Maximum aerobic velocity (VAM) in km·h^-1 VAM was calculated as the minimum speed that elicits maximum oxygen consumption. VAM is one of the physiological determinants of endurance performance. An increase in VAM velocity over time is an indication of improved performance |
Baseline and after 6 weeks | |
Primary | Change from Baseline of 7-km Time Trial Performance | Before and after 6 weeks, the final time achieved in a 7-km time trial performance was calculated for all participants.
The athletes were instructed to achieve their best performance on the 7-km. The test was performed in a 400m regulation athletic track. Verbal encouragement was given to all runners in both tests every 400-m lap. Participants used the same shoe model in the two tests and were asked not to use stimulants (coffee, tea, etc.). They performed the tests at the same time of day ± (2 hours). A decrease in the final time in the second test, indicates an improvement in performance |
Baseline and after 6 weeks | |
Primary | Change from Baseline of the First Physiological Thresholds (VT1) | Ventilatory thresholds (VT1 and VT2), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.
Were measured changes in: - Velocity associated with the first ventilatory threshold (VT1) in km·h^-1 Velocity zones corresponding to VT1 indicates a low intensity zone. An increase over time in VT1 indicates an improvement of the aerobic system |
Baseline and after 6 weeks | |
Primary | Change from Baseline of the second Physiological Thresholds (VT2) | Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.
Were measured changes in: - Velocity associated with the second ventilatory threshold (VT2) in km·h^-1. Intensity zones corresponding to VT2 indicates a high intensity zone. An increase over time in VT2 indicates an improvement in the anaerobic system |
Baseline and after 6 weeks | |
Primary | Change from baseline in HR associated with the first ventilatory threshold | Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.
were measured changes in: - HR associated with the first ventilatory threshold HR-VT1 in beats per minute (bpm). A lower HR associated with VT1, indicates an improvement of the aerobic system over time |
Baseline and after 6 weeks | |
Primary | Change from baseline in HR associated with the second ventilatory threshold | Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.
were measured changes in: - HR associated with the second ventilatory threshold (HR-VT12) in beats per minute (bpm). Higher HR associated with VT2, indicates an improvement of the anaerobic system over time |
Baseline and after 6 weeks | |
Secondary | Change of Rate of Perceived Exertion (RPE) scale after 6 weeks protocol | Participants indicated Rating of perceived exertion (RPE) using Borg's 6-20 validated scale, an exertion perception scale used during laboratory testing. RPE values were measured for both the running economy and during the incremental maximal test (VO2max).
The RPE values are: 6. = no exertion at all 7. = extremely light 9. = very light 11. = light 13. = somewhat hard 15. = hard (heavy) 17. = very hard 19. = extremely hard A decrease in RPE over time for the same intensity (e.g., same speed achieved in tests) indicates better performance adaptation |
Baseline and after 6 weeks | |
Secondary | Changes in Body Weight | Participants were weighed before and after the study to calculate body composition analysis. Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).
it was measured: - Body weight (kg) |
Baseline and after 6 weeks | |
Secondary | Changes in Height (cm) | Participants were weighed before and after the study to calculate body composition analysis.
Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours). it was measured: - Height (cm) |
Baseline and after 6 weeks | |
Secondary | Changes in BMI (kg/m^2) | Participants were weighed before and after the study to calculate body composition analysis:
Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours). it was measured: - BMI (kg/m^2) |
Baseline and after 6 weeks | |
Secondary | Changes in Fat mass | Participants were weighed before and after the study to calculate body composition analysis:
Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours). it was measured: - Fat mass (%) |
Baseline and after 6 weeks | |
Secondary | Changes in Free Fat Mass | Participants were weighed before and after the study to calculate body composition analysis:
Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours). it was measured: - Free fat mass (%) |
Baseline and after 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |